CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 (LIGHT 1) - BEIGE- octinoxate powder 
CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 (LIGHT 2) - BEIGE- octinoxate powder 
CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 (MEDIUM 1) - BEIGE- octinoxate powder 
CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 (MEDIUM 2) - BEIGE- octinoxate powder 
CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 (MEDIUM 3) - BEIGE- octinoxate powder 
CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 (MEDIUM 4) - BROWN- octinoxate powder 
CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 (OBSCURE 1) - BROWN- octinoxate powder 
Ventura Corporation LTD

----------

CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20

Drug Facts

Active Ingredients

OCTINOXATE 5.00%

Purpose

Sunscreen

Uses

  • Helps prevent sunburn.

Warnings

  • Skin Cancer / Skin Aging Alert:Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, notskin cancer or early skin aging.
  • For external use only.

  • Do not useon damaged or broken skin.

  • When using this productkeep out of eyes. Rinse with water to remove.

  • Stop use and ask a doctor ifrash occurs.

  • Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • Apply liberally and evenly 15 minutes before sun exposure.
  • Reapply at least every 2 hours
  • Use a water resistant sunscreen if swimming or sweating.
  • Children under 6 months of age: Ask a doctor

Other information

  • Protect the product in this container from excessive heat and direct sun.

Inactive ingredients

MICA, TALC, ZINC STEARATE, BORON NITRIDE, DIMETHICONE, OCTYLDODECANOL, TRIMETHYLSILOXYSILICATE, METHYL METHACRYLATE CROSSPOLYMER, PERFLUOROOCTYL TRIETHOXYSILANE, TOCOPHERYL ACETATE, MAGNESIUM MYRISTATE, PHENOXYETHANOL, CAPRYLYL GLYCOL, FRAGRANCE, CHLORPHENESIN.

MAY CONTAIN:
TITANIUM DIOXIDE, IRON OXIDES.

PUERTO RICO:Dist. by Ventura Corp, Ltd., San Juan, Puerto Rico 00926.

PRINCIPAL DISPLAY PANEL - 7 g Tube Box - (LIGHT 1) - BEIGE

cy°zone

STUDIO
LOOK
cy°zone

POLVOSCOMPACTOS DE ALTA
COBERTURA CON FPS 20

Net Wt. 0.24 oz. (7g.)

PRINCIPAL DISPLAY PANEL - 7 g Tube Box - (LIGHT 1) - BEIGE

PRINCIPAL DISPLAY PANEL - 7 g Tube Box - (LIGHT 2) - BEIGE

cy°zone

STUDIO
LOOK
cy°zone

POLVOSCOMPACTOS DE ALTA
COBERTURA CON FPS 20

Net Wt. 0.24 oz. (7g.)

PRINCIPAL DISPLAY PANEL - 7 g Tube Box - (LIGHT 2) - BEIGE

PRINCIPAL DISPLAY PANEL - 7 g Tube Box - (MEDIUM 1) - BEIGE

cy°zone

STUDIO
LOOK
cy°zone

POLVOSCOMPACTOS DE ALTA
COBERTURA CON FPS 20

Net Wt. 0.24 oz. (7g.)

PRINCIPAL DISPLAY PANEL - 7 g Tube Box - (MEDIUM 1) - BEIGE

PRINCIPAL DISPLAY PANEL - 7 g Tube Box - (MEDIUM 2) - BEIGE

cy°zone

STUDIO
LOOK
cy°zone

POLVOSCOMPACTOS DE ALTA
COBERTURA CON FPS 20

Net Wt. 0.24 oz. (7g.)

PRINCIPAL DISPLAY PANEL - 7 g Tube Box - (MEDIUM 2) - BEIGE

PRINCIPAL DISPLAY PANEL - 7 g Tube Box - (MEDIUM 3) - BEIGE

cy°zone

STUDIO
LOOK
cy°zone

POLVOSCOMPACTOS DE ALTA
COBERTURA CON FPS 20

Net Wt. 0.24 oz. (7g.)

PRINCIPAL DISPLAY PANEL - 7 g Tube Box - (MEDIUM 3) - BEIGE

PRINCIPAL DISPLAY PANEL - 7 g Tube Box - (MEDIUM 4) - BROWN

cy°zone

STUDIO
LOOK
cy°zone

POLVOSCOMPACTOS DE ALTA
COBERTURA CON FPS 20

Net Wt. 0.24 oz. (7g.)

PRINCIPAL DISPLAY PANEL - 7 g Tube Box - (MEDIUM 4) - BROWN

PRINCIPAL DISPLAY PANEL - 7 g Tube Box - (OBSCURE 1) - BROWN

cy°zone

STUDIO
LOOK
cy°zone

POLVOSCOMPACTOS DE ALTA
COBERTURA CON FPS 20

Net Wt. 0.24 oz. (7g.)

PRINCIPAL DISPLAY PANEL - 7 g Tube Box - (OBSCURE 1) - BROWN
CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20  (LIGHT 1) - BEIGE
octinoxate powder
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:13537-482
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE0.05 g  in 1 g
Inactive Ingredients
Ingredient NameStrength
MICA (UNII: V8A1AW0880)  
TALC (UNII: 7SEV7J4R1U)  
ZINC STEARATE (UNII: H92E6QA4FV)  
BORON NITRIDE (UNII: 2U4T60A6YD)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
OCTYLDODECANOL (UNII: 461N1O614Y)  
PERFLUOROOCTYL TRIETHOXYSILANE (UNII: 814P46684U)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
MAGNESIUM MYRISTATE (UNII: Z1917F0578)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
CHLORPHENESIN (UNII: I670DAL4SZ)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:13537-482-011 in 1 BOX08/24/201512/31/2021
17 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM02008/24/201512/31/2021
CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20  (LIGHT 2) - BEIGE
octinoxate powder
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:13537-483
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE0.05 g  in 1 g
Inactive Ingredients
Ingredient NameStrength
MICA (UNII: V8A1AW0880)  
TALC (UNII: 7SEV7J4R1U)  
ZINC STEARATE (UNII: H92E6QA4FV)  
BORON NITRIDE (UNII: 2U4T60A6YD)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
OCTYLDODECANOL (UNII: 461N1O614Y)  
PERFLUOROOCTYL TRIETHOXYSILANE (UNII: 814P46684U)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
MAGNESIUM MYRISTATE (UNII: Z1917F0578)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
CHLORPHENESIN (UNII: I670DAL4SZ)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:13537-483-011 in 1 BOX08/24/201512/31/2021
17 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM02008/24/201512/31/2021
CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20  (MEDIUM 1) - BEIGE
octinoxate powder
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:13537-484
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE0.05 g  in 1 g
Inactive Ingredients
Ingredient NameStrength
MICA (UNII: V8A1AW0880)  
TALC (UNII: 7SEV7J4R1U)  
ZINC STEARATE (UNII: H92E6QA4FV)  
BORON NITRIDE (UNII: 2U4T60A6YD)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
OCTYLDODECANOL (UNII: 461N1O614Y)  
PERFLUOROOCTYL TRIETHOXYSILANE (UNII: 814P46684U)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
MAGNESIUM MYRISTATE (UNII: Z1917F0578)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
CHLORPHENESIN (UNII: I670DAL4SZ)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:13537-484-011 in 1 BOX08/24/201512/31/2021
17 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM02008/24/201512/31/2021
CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20  (MEDIUM 2) - BEIGE
octinoxate powder
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:13537-485
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE0.05 g  in 1 g
Inactive Ingredients
Ingredient NameStrength
MICA (UNII: V8A1AW0880)  
TALC (UNII: 7SEV7J4R1U)  
ZINC STEARATE (UNII: H92E6QA4FV)  
BORON NITRIDE (UNII: 2U4T60A6YD)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
OCTYLDODECANOL (UNII: 461N1O614Y)  
PERFLUOROOCTYL TRIETHOXYSILANE (UNII: 814P46684U)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
MAGNESIUM MYRISTATE (UNII: Z1917F0578)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
CHLORPHENESIN (UNII: I670DAL4SZ)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:13537-485-011 in 1 BOX08/24/201512/31/2021
17 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM02008/24/201512/31/2021
CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20  (MEDIUM 3) - BEIGE
octinoxate powder
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:13537-486
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE0.05 g  in 1 g
Inactive Ingredients
Ingredient NameStrength
MICA (UNII: V8A1AW0880)  
TALC (UNII: 7SEV7J4R1U)  
ZINC STEARATE (UNII: H92E6QA4FV)  
BORON NITRIDE (UNII: 2U4T60A6YD)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
OCTYLDODECANOL (UNII: 461N1O614Y)  
PERFLUOROOCTYL TRIETHOXYSILANE (UNII: 814P46684U)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
MAGNESIUM MYRISTATE (UNII: Z1917F0578)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
CHLORPHENESIN (UNII: I670DAL4SZ)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:13537-486-011 in 1 BOX08/24/201512/31/2021
17 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM02008/24/201512/31/2021
CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20  (MEDIUM 4) - BROWN
octinoxate powder
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:13537-487
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE0.05 g  in 1 g
Inactive Ingredients
Ingredient NameStrength
MICA (UNII: V8A1AW0880)  
TALC (UNII: 7SEV7J4R1U)  
ZINC STEARATE (UNII: H92E6QA4FV)  
BORON NITRIDE (UNII: 2U4T60A6YD)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
OCTYLDODECANOL (UNII: 461N1O614Y)  
PERFLUOROOCTYL TRIETHOXYSILANE (UNII: 814P46684U)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
MAGNESIUM MYRISTATE (UNII: Z1917F0578)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
CHLORPHENESIN (UNII: I670DAL4SZ)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:13537-487-011 in 1 BOX08/24/201512/31/2021
17 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM02008/24/201512/31/2021
CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20  (OBSCURE 1) - BROWN
octinoxate powder
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:13537-488
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE0.05 g  in 1 g
Inactive Ingredients
Ingredient NameStrength
MICA (UNII: V8A1AW0880)  
TALC (UNII: 7SEV7J4R1U)  
ZINC STEARATE (UNII: H92E6QA4FV)  
BORON NITRIDE (UNII: 2U4T60A6YD)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
OCTYLDODECANOL (UNII: 461N1O614Y)  
PERFLUOROOCTYL TRIETHOXYSILANE (UNII: 814P46684U)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
MAGNESIUM MYRISTATE (UNII: Z1917F0578)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
CHLORPHENESIN (UNII: I670DAL4SZ)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:13537-488-011 in 1 BOX08/24/201512/31/2021
17 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM02008/24/201512/31/2021
Labeler - Ventura Corporation LTD (602751344)
Establishment
NameAddressID/FEIBusiness Operations
Bel Star S.A. (Colombia)880160197manufacture(13537-482, 13537-483, 13537-484, 13537-485, 13537-486, 13537-487, 13537-488)

Revised: 4/2025
 
Ventura Corporation LTD